ProCE Banner Activity

CE / CME

Expert Insights on Targeting Residual Inflammatory Risk in ASCVD and CKD

Text Module

Learn about the pivotal role nephrology healthcare professionals have in caring for patients with ASCVD and CKD, including addressing systemic or residual inflammation with novel therapies.

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Nurses: 1.00 Nursing contact hour

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Released: July 22, 2024

Expiration: July 21, 2025

Share

Faculty

Erin Michos

Erin Michos, MD, MHS, FACC, FAHA, FASE, FASPC

Professor of Medicine
Director of Women’s Cardiovascular Health Research
Associate Director of Preventive Cardiology
Division of Cardiology
Johns Hopkins University School of Medicine
Co Center-Director, IMPACT Center at JHU
(Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials)
Co-Editor in Chief
American Journal of Preventive Cardiology
Baltimore, Maryland

Provided by

Provided by Clinical Care Options, LLC in partnership with American Kidney Fund

ProCE Banner

Supporters

Supported by an educational grant from Novo Nordisk.

Novo Nordisk

Partners

American Kidney Fund

ProCE Banner

Target Audience

This program is intended for nephrology physicians, nurse practitioners, physician associates, and other healthcare professionals who care for patients with ASCVD, systemic inflammation, and CKD.

Program Learning Goal

The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Cardiovascular Disease (CVD).

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Recognize the responsibility of nephrology specialists in minimizing the risk of ASCVD in individuals with CKD by leveraging hsCRP as a standard biomarker of inflammatory burden

  • Summarize the mechanistic role of systemic inflammation in ASCVD risk in patients with CKD

  • Integrate evidence for new and emerging agents for ASCVD management targeting residual inflammatory risk into individualized treatment plans for patients with CKD

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Erin Michos, MD, MHS, FACC, FAHA, FASE, FASPC

Professor of Medicine
Director of Women’s Cardiovascular Health Research
Associate Director of Preventive Cardiology
Division of Cardiology
Johns Hopkins University School of Medicine
Co Center-Director, IMPACT Center at JHU
(Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials)
Co-Editor in Chief
American Journal of Preventive Cardiology
Baltimore, Maryland

Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC: consultant/advisor/speaker: Amgen, Arrowhead, AstraZeneca, Boehringer Ingelheim, Edwards Lifescience, Ionis, Lilly, Medtronic, Merck, New Amsterdam, Novartis, Novo Nordisk, Pfizer.

The planners and content peer reviewers from Clinical Care Options, LLC and American Kidney Fund do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from July 22, 2024, through July 21, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO) and American Kidney Fund. Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour.

Physician Associate Continuing Medical Education

LogoDescription automatically generated

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credit. Approval is valid until July 21, 2025. PAs should only claim credit commensurate with the extent of their participation.

CME Passport

662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.